AI Article Synopsis
- - Zika virus (ZIKV) is a mosquito-borne virus first identified in Uganda in 1947, with various outbreaks reported globally since then.
- - It can be transmitted not only by mosquitoes but also through sexual contact, mother-to-child, and blood transfusions, with symptoms resembling those of dengue and chikungunya.
- - Although most infections are mild, ZIKV can lead to serious conditions like congenital microcephaly and Guillain-Barré syndrome; there are currently no specific treatments or vaccines, emphasizing the importance of preventive measures.
Article Abstract
Zika virus (ZIKV) is a mosquito-borne virus that was first isolated from Zika forest, Uganda, in 1947. Since its inception, major and minor outbreaks have been documented from several parts of world. spp. mosquitoes are the primary vectors of ZIKV, but the virus can also be transmitted through sexual practices, materno-fetal transmission, and blood transfusion. The clinical presentations of symptomatic ZIKV infections are similar to dengue and chikungunya, including fever, headache, arthralgia, retro-orbital pain, conjunctivitis, and rash. ZIKV often causes mild illness in the majority of cases, but in some instances, it is linked with congenital microcephaly and autoimmune disorders like Guillain-Barré syndrome. The recent Indian ZIKV outbreak suggests that the virus is circulating in the South East Asian region and may cause new outbreaks in future. At present, no specific vaccines or antivirals are available to treat ZIKV, so management and control of ZIKV infections rely mostly on preventive measures.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1139/cjm-2019-0331 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!